23 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Tetraphase Competitors or Alternatives

Tetraphase's top competitors include BioCryst, Spero Therapeutics and Adamas.

Unlock 9 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Tetraphase's company profile

Larry Edwards

CEO

93/100
25 - 100
$172M
$5M - 25M
  • $172M
    $5M - 25M
  • 25 - 100
    $172M
  • $5M - 25M
  • 93/100
  • 25 - 100
  • $172M
  • $5M - 25M
View ProfileView
1
Tetraphase's Competitor - BioCryst logo

Jon P. Stonehouse

President & CEO

61/100
530
$1.5B
$450.7M
  • $1.5B
    $450.7M
  • 530
    $1.5B
  • $450.7M
  • 61/100
  • 530
  • $1.5B
  • $450.7M
View ProfileView
2
Tetraphase's Competitor - Spero Therapeutics logo

Sath Shukla

President & CEO

82/100
150
$463.8M
$48M
  • $463.8M
    $48M
  • 150
    $463.8M
  • $48M
  • 82/100
  • 150
  • $463.8M
  • $48M
View ProfileView
3
Tetraphase's Competitor - Adamas logo

CEO

- -
100 - 250
$88M
$25M - 100M
  • $88M
    $25M - 100M
  • 100 - 250
    $88M
  • $25M - 100M
  • - -
  • 100 - 250
  • $88M
  • $25M - 100M
View ProfileView
4
Tetraphase's Competitor - Melinta logo

Christine Ann Miller

President & CEO

88/100
250 - 500
$558.3M
$25M - 100M
  • $558.3M
    $25M - 100M
  • 250 - 500
    $558.3M
  • $25M - 100M
  • 88/100
  • 250 - 500
  • $558.3M
  • $25M - 100M
View ProfileView
5
Tetraphase's Competitor - Allergan logo

CEO

- -
10,000 - 50,000
$31.1M
$10B - 50B
  • $31.1M
    $10B - 50B
  • 10,000 - 50,000
    $31.1M
  • $10B - 50B
  • - -
  • 10,000 - 50,000
  • $31.1M
  • $10B - 50B
View ProfileView
Tetraphase's top 12 competitors are BioCryst, Spero Therapeutics, Adamas, Iterum Therapeutics, Melinta, Allergan, AstraZeneca, Polyphor, Achaogen, Interchem Corporation, Olon and Basilea. Together they have raised over 3.4B between their estimated 110.5K employees. Tetraphase's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 5.3B. Tetraphase has 66 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 8,501.

Tetraphase VS BioCryst

BioCryst is seen as one of Tetraphase's top competitors. BioCryst was founded in Durham, North Carolina} in 1986. BioCryst is in the Biotechnology industry. Compared to Tetraphase, BioCryst generates $442.8M more revenue.

Tetraphase VS Spero Therapeutics

Spero Therapeutics is Tetraphase's #2 competitor. Spero Therapeutics was founded in 2013, and its headquarters is in Cambridge, Massachusetts. Spero Therapeutics competes in the Pharmaceuticals industry. Spero Therapeutics has 84 more employees than Tetraphase.

Tetraphase VS Adamas

Adamas is Tetraphase's #3 rival. Adamas is headquartered in Emeryville, California, and was founded in 2002. Like Tetraphase, Adamas also competes in the Pharmaceuticals industry. Adamas generates 942% the revenue of Tetraphase.

Looking for similar companies to Tetraphase?

Similar Companies

Pharmaceuticals companies in Waltham

See 37 companies 
Pharmaceuticals companies in Greater Boston

See 500 companies 
Pharmaceuticals & Biotechnology companies in Waltham

See 122 companies 
Pharmaceuticals companies in Massachusetts

See 516 companies 
Companies in Waltham with revenue in $5.0-25M range

See 892 companies 
Companies in Waltham with employees in 25-100 range

See 1,201 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,718 companies 
Pharmaceuticals companies with revenue in $5.0-25M range

See 2,472 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Tetraphase and Tetraphase's Competitors

April 30, 2025Marketscreener
RESEARCH TRIANGLE PARK, N.C. , April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans ...
April 30, 2025centralcharts
DUBLIN, Ireland and CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a company focused on delivering n...
Today 7:02 AMNasdaq
(RTTNews) - AstraZeneca Plc.'s (AZN.L, AZN) triple-combination inhaler, Breztri Aerosphere, has shown positive results in late-stage clinical trials fo...
April 30, 2025Benzinga
NOVATO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development...
April 30, 2025Pharmabiz
AstraZeneca is discontinuing the CAPItello─280 phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxe...
April 30, 2025Yicai Global
May 1, 2025The Hindu Business Line
In 2020, AstraZeneca partnered with Qure.ai to leverage its technology for assessing chest X-rays and determining potential lung cancer risk....
April 30, 2025Valuespectrum
Analyze global market size and segmentation. Assess market shares, competitiveness and industry structure. Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- T...
May 1, 2025Businessinsider
Morgan Stanley lowered the firm's price target on AstraZeneca ( AZN ) to 13,700 GBp from 14,500 GBp and keeps an Overweight rating on the shares. Prote...

Frequently Asked Questions about Tetraphase

  1. Who are Tetraphase's top competitors?

    Tetraphase's top 3 competitors are BioCryst, Spero Therapeutics, Adamas.

  2. Who is similar to Tetraphase?

    BioCryst is the most similar to Tetraphase. Spero Therapeutics and Adamas are also similar to Tetraphase.

  1. Are Tetraphase and BioCryst competitors?

    Yes, BioCryst is one of Tetraphase’s top competitors.